| # | Drug | Count |
|---|---|---|
| 0 | INSULIN LISPRO | 26 |
| 1 | INSULIN HUMAN | 22 |
| 2 | INSULIN GLARGINE | 14 |
| 3 | METFORMIN | 14 |
| 4 | METFORMIN ER 500 MG | 14 |
| 5 | METFORMIN ER 750 MG | 14 |
| 6 | QUETIAPINE | 9 |
| 7 | INSULIN ASPART | 8 |
| 8 | VALSARTAN | 6 |
| 9 | INSULIN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOMATROGON-GHLA | 1 | 0.0008 |
| 1 | PRAZOSIN HYDROCHLORIDE | 1 | 0.0007 |
| 2 | POTASSIUM ACETATE | 1 | 0.0007 |
| 3 | INSULIN HUMAN | 22 | 0.0006 |
| 4 | LEVONORGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0004 |
| 5 | CINNAMON | 1 | 0.0003 |
| 6 | PHENAZOPYRIDINE | 1 | 0.0003 |
| 7 | ENFORTUMAB VEDOTIN | 2 | 0.0003 |
| 8 | LANREOTIDE ACETATE | 2 | 0.0003 |
| 9 | PEGVISOMANT | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 43 |
| 1 | Insulin [EPC] | 22 |
| 2 | GLP-1 Receptor Agonist [EPC] | 12 |
| 3 | Corticosteroid [EPC] | 11 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 7 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7 |
| 6 | Benzodiazepine [EPC] | 6 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 6 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 5 |
| 9 | Atypical Antipsychotic [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Insulin [EPC] | 22 | 0.0005 |
| 1 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 2 | Asparagine-specific Enzyme [EPC] | 2 | 0.0001 |
| 3 | Insulin Analog [EPC] | 43 | 0.0001 |
| 4 | Nitrate Vasodilator [EPC] | 4 | 0.0000 |
| 5 | Progesterone [EPC] | 1 | 0.0000 |
| 6 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 4 | 0.0000 |
| 7 | Dietary Cholesterol Absorption Inhibitor [EPC] | 3 | 0.0000 |
| 8 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 9 | GLP-1 Receptor Agonist [EPC] | 12 | 0.0000 |